Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

365 results about "Androgen" patented technology

An androgen (from Greek andr-, the stem of the word meaning "man") is any natural or synthetic steroid hormone that regulates the development and maintenance of male characteristics in vertebrates by binding to androgen receptors. This includes the embryological development of the primary male sex organs, and the development of male secondary sex characteristics at puberty. Androgens are synthesized in the testes, the ovaries, and the adrenal glands.

Composite hydrogel as well as preparation method and application thereof

The invention discloses composite hydrogel as well as a preparation method and application thereof. The curcumin-EGCG composite hydrogel is prepared by forming a complex through hydrogen-bond interaction between gelatin and epigallocatechin gallate and carrying out chemical crosslinking through Schiff base reaction of curcumin and gelatin. The composite hydrogel disclosed by the invention has a self-healing characteristic or viscosity and a shear thinning characteristic, and is beneficial to local application. The composite hydrogel is loose and porous in structure, the drug loading rate can be increased, the drug can be slowly and controllably released, the treatment effect of the composite hydrogel in androgenetic alopecia is promoted, meanwhile, the solubility of a drug monomer can be remarkably improved, and the problem that the drug solubility is low is solved. The composite hydrogel provided by the invention provides an effective transdermal drug delivery preparation for treatment of skin diseases, and has good clinical application prospects and development values.
Owner:GUANGZHOU UNIVERSITY OF CHINESE MEDICINE

Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy

ActiveUS12156881B2Organic active ingredientsDrug and medicationsTridecanoinGonad function
Disclosed are pharmaceutical compositions and oral dosage forms including capsules containing (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate, and related methods. The capsule fill can include an additive and about 14 wt % to about 42 wt % for androst-4-en-17β-ol-3-one esters that comprise (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate or a combination of (17-ß)-3-oxoandrost-4-en-17-yl undecanoate, (17-ß)-3-oxoandrost-4-en-17-yl dodecanoate, and (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate. A single oral administration to a male subject of one or more dosage forms with a total androst-4-en-17β-ol-3-one equivalent dose of about 150 mg to about 895 mg is provided. In another embodiment, a method for providing a serum concentration of androst-4-en-17β-ol-3-one within a target PK performance for a male subject is provided. In a further embodiment, the pharmaceutical compositions and methods comprising androst-4-en-17β-ol-3-one ester loading of 14 wt % to 42 wt % achieve androst-4-en-17β-ol-3-one PK performance targets and require titration(s) to show therapeutic effectiveness for treatment of hypogonadism.
Owner:LIPOCINE INC

Compositions for non-surgical prevention of boar taint and aggressive behavior

Embodiments of the present invention provide a pharmaceutical intervention in the neonatal pig that inhibits and delays development and activation of the HPG axis, growth of the boar testis and inhibits testicular production of testosterone and androstenone, which prevents the development of aggressive behavior in the maturing boars and the presence of boar taint in the meat. The invention comprises treatment with a combination of an androgen and an estrogen in the newborn male piglet using extended drug delivery methods, with a defined duration of no more than 12 weeks, for the purpose of inhibiting the production of testosterone and androstenone and the accumulation of the boar taint-inducing molecules androstenone and skatole in the fat.
Owner:INSIGNA INC

Product capable of treating androgen alopecia and / or promoting hair growth and application of exosome

The invention discloses a product capable of treating androgenetic alopecia and / or promoting hair growth and application of exosomes, the product comprises the product capable of treating androgenetic alopecia and / or promoting hair growth, and is characterized by comprising the exosomes obtained by stimulating mesenchymal stem cells through CHIR99021 and minoxidil combined with the exosomes. The disclosure verifies that the exosome obtained by stimulating mesenchymal stem cells through CHIR99021 can promote hair growth and treat androgenetic alopecia, and particularly, the hair growth effect is better when the exosome is combined with minoxidil, so that a product comprising the exosome and minoxidil can treat androgenetic alopecia and promote hair growth is provided.
Owner:SHANDONG UNIV QILU HOSPITAL

Application of platelet reaction protein 4 in preparation of medicine for treating alopecia

The invention relates to application of a platelet reaction protein 4 in preparation of an alopecia medicine, and belongs to the field of medical biology. The invention aims to solve the technical problems of limited curative effect, obvious side effect and narrow application range of the existing alopecia treatment medicine. The invention provides an application of a platelet reaction protein 4 (THBS4) in preparation of an alopecia medicinal preparation, which can promote hair follicles to be converted from a resting period to a growing period by regulating and controlling a mechanical microenvironment around the hair follicles, enhancing the interaction between fibroblasts and hair follicle stem cells and activating regeneration signal channels in hair papilla and hair bud areas. The traditional Chinese medicine composition breaks through the limitation that existing treatment only aims at specific alopecia types, and can be widely applied to various alopecia diseases such as androgenetic alopecia, pressure alopecia and alopecia after chemotherapy. And compared with the traditional medicine, the traditional Chinese medicine composition has the advantages of quick response, no skin irritation reaction and improved hair follicle regeneration efficiency, and provides a brand new solution for safe and efficient treatment of alopecia.
Owner:CHONGQING UNIV

Hybrid vesicle composition containing finasteride and nanogold as well as preparation and application of hybrid vesicle composition

The invention discloses a hybrid vesicle composition containing finasteride and nanogold. The composition is prepared from hair follicle stem cell outer vesicles, lipidosome, finasteride and nanogold, according to the method, the treatment efficiency of finasteride on androgenetic alopecia is enhanced by utilizing the delivery property of a mediated hair recovery mechanism pathway and a homing effect of heterozygous hair follicle stem cell outer vesicles to a hair follicle microenvironment and assisting with a photothermal effect provided by nanogold light conversion, and the method can be widely applied to the fields of medical cosmetology and pharmacy.
Owner:JINHUA PULIJIAN MEDICAL TECHNOLOGY CO LTD

Sulfur ketal bond modified 17-type collagen dopamine drug-loaded nanoparticle composite microneedle patch as well as preparation method and application thereof

The invention relates to the field of biological materials, in particular to a thioketal bond modified 17-type collagen dopamine drug-loaded nanoparticle composite microneedle patch and a preparation method and application thereof, and the microneedle patch is composed of dopamine drug-loaded nanoparticles, thioketal bond modified recombinant 17-type collagen and a polymer substrate. The thioketal bond modified 17-type collagen and polyvinyl alcohol are subjected to physical and chemical double-crosslinking to form hydrogel, then the hydrogel is loaded with drug-loaded nanoparticles, and the hydrogel and a polymer substrate form the ROS and pH value microenvironment double-response collagen microneedle patch loaded with bioactive substances. When the collagen hydrogel is applied to the skin, the tip of the microneedle reaches the area where the hair follicle stem cells exist in a painless and minimally invasive mode, and due to the change of microenvironment molecules in the skin tissue, the breakage of thioketal bonds in the collagen hydrogel can be promoted, so that active oxygen is removed, and the wrapped IGF-1 is released into the hair follicle stem cells; and a potential treatment strategy is provided for androgenetic alopecia.
Owner:CHANGZHOU UNIV

METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and / or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect. The present disclosure also provides for methods for treating prostate cancer in a patient with a history of at least one cardiovascular event, wherein administration of degarelix to the subject decreases the likelihood of developing or experiencing an additional cardiovascular event compared to treatment with a gonadotrophin releasing hormone (GnRH) agonist.
Owner:FERRING BV

Topical composition comprising clascoterone and latanoprost for alopecia

PCT designated stage expiredWO2025149998A1Organic active ingredientsOrganic non-active ingredientsPropionateLatanoprost
The present invention relates to the topical pharmaceutical composition comprising about 0.001% w / w to about 1% w / w latanoprost and about 1% w / w to about 15% w / w cortexolone-17α-propionate and a pharmaceutically acceptable vehicle comprising one or more solvent and process of its preparation. The invention further relates to the method wherein the composition is suitable for preventing and / or treating hair loss and / or stimulating hair growth. in patients suffering from alopecia, in particular androgenic alopecia (AGA).
Owner:GLENMARK SPECIALTY

Method for breeding all-male hybrid pelteobagrus fulvidraco through hybridization of double super-male populations

The invention provides a method for breeding all-male hybrid pelteobagrus fulvidraco through hybridization of double super-male populations, which comprises the following steps: S1, respectively constructing super-male maintenance lines of pelteobagrus fulvidraco and pelteobagrus vachelli by utilizing a sex reversal technology and a sex molecular marker; s2, carrying out artificial propagation on the maintenance line, and propagating the super male fish in batches; s3, partially replacing estrogen with an androgen antagonist for the propagated supermale fish, and synergistically inducing the supermale fish to obtain superfemale fish; s4, performing specific nutrient enrichment cultivation on the super female fish and the super male parent fish; and S5, carrying out reciprocal cross artificial propagation on the super-female fish and the super-male fish between the two super-male groups to obtain a heterozygous super-male group, namely commercial fry of the all-male hybrid pelteobagrus fulvidraco. According to the technical scheme, super-female fishes can be efficiently induced in batches, high-density breeding of parent fishes is achieved, and the effect and efficiency of artificial breeding are remarkably improved; the bred hybrid all-realgar catfish is high in individual uniformity, the growth speed is increased by 20%, and the male rate reaches 100%.
Owner:ZHAOQING JIAYI AQUATIC TECHNOLOGY CO LTD +2

Blood-generating preparation for treating male hormone alopecia as well as preparation method and application of blood-generating preparation

The invention discloses a hematopoietic preparation for treating androgenetic alopecia and a preparation method of the hematopoietic preparation. The hematopoietic preparation is prepared from 5-30 parts of radix polygoni multiflori preparata, 5-30 parts of wine ligustrum lucidum ait, 5-30 parts of mulberry, 5-30 parts of eclipta, 5-30 parts of radix paeoniae alba, 5-30 parts of astragalus membranaceus and 5-30 parts of rhizoma cibotii. The medicine composition and the specific dosage are obtained through a large number of experimental screening and clinical medication experience screening. The whole formula takes tonifying liver and kidney and benefiting essence and blood as the monarch, and takes tonifying spleen and qi and removing heat to cool blood as the minister and assistant, based on the traditional Chinese medicine theory that essence is stored in kidney and is warmed on hair, by inhibiting DHT generation, resisting hair follicle apoptosis and improving scalp microcirculation, the traditional Chinese medicine composition has the remarkable effect of treating androgenetic alopecia, is weak in toxic and side effects, and can be prepared into various clinical dosage forms.
Owner:SHAANXI UNIV OF CHINESE MEDICINE

Prediction of results of neoadjuvant androgen deprivation therapy for prostate cancer subjects

The present invention relates to methods of predicting the response of prostate cancer subjects to neohelper androgen deprivation therapy. The method is based on prediction results based on gene expression levels identified herein. The present invention provides a method for determining whether neoadjuvant androgen deprivation therapy is useful for a subject and thus should be administered. Further provided is the use of a kit for determining the expression level for predicting the response of a prostate cancer subject to neohelper androgen deprivation therapy.
Owner:KONINKLIJKE PHILIPS NV

Self-assembled polypeptide with IGF-1 function and hair growth application thereof

The invention relates to the technical field of biological medicine, and provides a self-assembly polypeptide with an IGF-1 function and hair growth application thereof, and the self-assembly polypeptide comprises an end-capping group, a self-assembly unit and an insulin-like growth factor C structural domain polypeptide IGF-1C which are connected in sequence. The self-assembled polypeptide with the IGF-1 function, provided by the invention, has a beta-folded secondary structure, and can simulate a binding mode of IGF-1 and an insulin-like growth factor receptor IGF-1R and induce conformational change of an IGF-1R dimer, so that phosphorylation of the IGF-1R is promoted, physiological functions of the IGF-1R are simulated, and growth of hair is promoted. The self-assembled polypeptide with the insulin-like growth factor 1 (IGF-1) function, provided by the invention, can be applied to an alopecia area in a skin smearing manner, and particularly shows an excellent hair growth promoting effect in a mouse physiological alopecia model and an androgenic alopecia model.
Owner:NANKAI UNIV

Double-stranded miRNA, pharmaceutical composition containing double-stranded miRNA, anti-aging product and application of double-stranded miRNA

The invention discloses a double-chain miRNA, a pharmaceutical composition containing the same, an anti-aging product and application of the double-chain miRNA. The double-stranded miRNA comprises a chemically modified sense strand with a sequence shown as SEQ ID NO: 1 and a chemically modified antisense strand with a sequence shown as SEQ ID NO: 2, wherein the chemical modification of the sense strand and the antisense strand each comprises a 2 '-substituted nucleotide and a modified nucleotide bond; the chemically modified nucleotide bond is at least located at one or more of the 1st-3rd and 20th-23rd sites of the sequence shown as SEQ ID NO: 1 and / or SEQ ID NO: 2. The double-chain miRNA is good in stability and has a remarkable treatment effect on skin cell photoaging, Alzheimer's disease, articular cartilage injury, diabetes, non-alcoholic fatty liver disease, androgenetic alopecia, cirrhosis and chronic nephritis. In short, the effect and the stability of the product are both considered, and the application prospect is good.
Owner:YUANSHENG BIOTECH (TSING DAO) CO LTD

Novel long-acting injectable composition comprising finasteride for prevention or treatment of androgenetic alopecia

PCT designated stage expiredWO2025144023A1Organic active ingredientsPharmaceutical delivery mechanismHormones sexAndrogen
The present invention relates to a novel long-acting injectable composition comprising finasteride for the prevention or treatment of androgenetic alopecia. The composition inhibits type II 5α-reductase with a single injection lasting over one month, thereby suppressing the conversion of testosterone to DHT and reducing androgen-mediated follicular miniaturization. In addition, after injection into the body, the average elimination half-life (T1 / 2el) of finasteride can be increased to enhance stability and provide more predictable and uniform therapeutic effects compared to oral formulations.
Owner:INVENTAGE LAB INC

Devices, systems, and methods for improved bone remodeling

Disclosed are devices and methods for providing local administration of a sex hormone composition in a mammalian body to promote bone remodeling. The device includes an implantable structure configured for placement at a target intraosseous and / or periosteal site in the mammalian body and an effective amount of a sex hormone composition associated with the implantable structure. The sex hormone composition comprises both an estrogen and an androgen.
Owner:UNIV OF UTAH RES FOUND

Use of JWA polypeptide in preparation of drug for resisting androgenetic alopecia

PCT designated stageWO2025222604A1Peptide/protein ingredientsPeptidesPhosphorylationHair shaft
The present invention relates to use of a JWA polypeptide in the preparation of a drug for resisting androgenetic alopecia. An amino acid sequence of the polypeptide is shown as I or II: I: FPGSDRF-Z; II: X-FPGSDRF-Z, wherein an amino acid S is subjected to phosphorylation modification, and X and Z are an amino acid or an amino acid sequence, respectively. The described JWA polypeptide can directly target integrin molecules onto hair follicle cells and enter the cells to play a role in regulating and controlling hair follicle proliferation, promoting hair growth and the like; the telogen phase of the hair follicles is significantly shortened, and the anagen phase of the hair follicles is prolonged; the hair shaft and follicle volume is increased; and the expression level of the target cell integrin molecule αvβ1 can be improved, and the hair follicle stem cell signal channel MEK / ERK / E2F1 / SP1 / Wnt10a / 10b / β-catenin can be accurately activated.
Owner:SUZHOU MINGREN PHARM BIOTECHNOLOGY CO LTD

Quickly separated microneedle patch as well as preparation method and application thereof

The invention discloses a rapidly-separated microneedle patch as well as a preparation method and application thereof. The microneedle patch comprises a needle tip prepared from a needle tip liquid and a separation backing prepared from a separation substrate liquid, the needle tip liquid is composed of a drug-containing clathrate compound solution, a photoinitiator and a hypotonic agent; the drug-containing clathrate compound is prepared by covalently connecting a beta-cyclodextrin conjugated polymer material with an angiogenesis promoting drug and then clathrating a 5alpha-reductase inhibitor, the separation substrate liquid is composed of a polymer material, a gas initiator and a solvent; the gas initiator is composed of an acid source and an alkali source; the rapid separation microneedle is high in separation and permeation promotion performance, the hair follicle microenvironment is improved from multiple aspects, hair regeneration is promoted, and the rapid separation microneedle has wide application prospects in treatment of androgen alopecia.
Owner:JINAN UNIVERSITY

CfRNA androgen alopecia early screening method and system based on machine learning model

PendingCN119132413AHigh qualitative synthesis powerimprove performanceEnsemble learningBiostatisticsData setScreening method
The invention discloses a cfRNA male hormone alopecia early screening method and system based on a machine learning model, and belongs to the field of male hormone alopecia, and the method comprises the following steps: extracting RNA from a sample set to obtain an RNA data set; constructing a library based on the RNA data set; performing quality inspection and NGS sequencing on the library to obtain sequencing data; performing bioinformatics analysis on the sequencing data to obtain significant differential genes; and establishing a prediction model by taking the significantly differential genes as input features of a random forest model, and inputting new sample information into the prediction model to obtain the alopecia risk of the subject corresponding to the sample.
Owner:深圳津渡生物医学科技有限公司

Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancer

Methods, compositions, and kits for identifying individuals who will be resistant to androgen deprivation therapy for treatment of prostate cancer are disclosed. In particular, the invention relates to an androgen deprivation therapy resistance signature based on expression levels of genes that are differentially expressed between responders and non-responders to androgen deprivation therapy and its use to identify individuals likely to respond poorly or be non-responsive to androgen deprivation therapy, who are in need of treatment for prostate cancer by other methods.
Owner:VERACYTE INC

Application of ezetimibe derivative in preparation of anti-prostatic cancer drugs

The invention relates to an application of an ezetimibe derivative in preparation of an anti-prostatic cancer drug, and belongs to the technical field of medicinal chemistry. The general formula structure of the ezetimibe derivative L14 is # imgabs0. The ezetimibe derivative L14 can be used for preparing new drugs for treating CRPC and NEPC without depending on an androgen receptor pathway, the clinical curative effect is improved, and the clinical drug selection is increased. The micromolecule L14-8 (R1 = R2 =-C (O) CH = CH2) can specifically inhibit proliferation of prostate cancer cells in vitro and can also inhibit growth of prostate tumors in vivo; in the aspect of drug combination, the AR antagonist and the low-dose small molecule L14-8 are combined for use, so that the sensitivity of CRPC and NEPC to the AR antagonist can be remarkably improved, the drug resistance induced by the AR antagonist can be possibly inhibited, and the clinical benefits of the AR antagonist can be improved.
Owner:SHANGHAI UNIV OF T C M

Application of vitamin K2 in preparation of anti-hair loss composition

The invention discloses application of vitamin K2 in preparation of an anti-hair loss composition. Research finds that the vitamin K2 has the effects of promoting VEGF gene expression and inhibiting IL-6 and DKK-1 gene expression in an androgen type alopecia model, and has the effects of promoting Gas6, VEGF and TGF gene expression in a pressure type alopecia model, so that a good alopecia prevention and treatment effect is achieved, and toxic and side effects are few.
Owner:PROYA COSMETICS CO LTD

Anti-hair-loss composition containing picea norvegensis leaf extract and application of anti-hair-loss composition

ActiveCN119896623ACosmetic preparationsHair cosmeticsBiotechnologySaw palmetto extract
The invention discloses an anti-hair loss composition containing picea norvegensis leaf extract and application, and relates to the technical field of cosmetics. The composition disclosed by the invention comprises a component A and a component B, wherein the component A comprises the following components in parts by weight: 1-5 parts of a verbasci extract, 0.1-1 part of a saw palmetto extract and 1-5 parts of a picea norvegensis leaf extract; the component B is prepared from the following ingredients in parts by weight: 2 to 4 parts of eucommia ulmoides bark extracts. According to the composition, the verbasci extract, the saw palmetto extract, the picea norvegensis leaf extract and the eucommia ulmoides bark extract are combined to have a synergistic effect, and the composition formed by specific compatibility of the components can prevent androgenetic alopecia from resisting inflammation and bacteria, inhibiting a TRPV3 channel and inhibiting the activity of 5 alpha-reductase; in addition, the plant components are selected, so that the oil-control composition is more suitable for men to use.
Owner:N O D TOPIA (GUANGZHOU) BIOTECHNOLOGY CO LTD

Anti-hair loss natural plant composition and application thereof

PendingCN119157795ACosmetic preparationsHair cosmeticsAndrogenVellus hair
The invention discloses an anti-hair-loss natural plant composition and application thereof. The anti-hair-loss natural plant composition comprises the following components: a cacumen biotae alcohol extract, a ginseng aqueous extract, a gynostemma pentaphylla alcohol extract and undaria pinnatifida crude polysaccharide. The anti-hair loss and hair growth activity of the composition is evaluated by establishing an androgenetic alopecia mouse model, the result shows that the composition can accelerate the transition of hair follicles of the androgenetic alopecia mouse from a resting period to a growing period, and the hair growth length of the androgenetic alopecia mouse model reaches 9.94 + / -0.13 mm 21 days after the composition is externally applied. The hair coverage rate reaches 96.74 + / -1.98%, the vellus hair proportion is 20.1%, and the composition can significantly improve the hair growth speed of mice with androgenetic alopecia.
Owner:TONGLING JIEYA BIOLOGIC TECH +1

Cell active peptide composition for resisting acnes and regulating skin micro-ecology, preparation method of cell active peptide composition and application of cell active peptide composition in medicine and beauty

InactiveCN119074893ARemoval of keratinizationRegulating MicroecologyOrganic active ingredientsCosmetic preparationsDipeptidePolylysine
The invention relates to a cell active peptide composition for resisting acnes and regulating skin micro-ecology, a preparation method thereof and application of the cell active peptide composition in medicine and beauty, and belongs to the technical field of medicine and beauty. The composition disclosed by the invention is prepared from a rhizoma coptidis extract, hydrolyzed zinc hyaluronate, azelaic acid, nisin, polylysine, palmitoyl tripeptide-8, palmitoyl tripeptide-5, dipeptide-15, capryloyl glycine, a lactobacillus fermentation extract and a bifidus yeast fermentation product lysate. The composition can balance peripheral androgen and reduce excessive secretion of sebum; hair follicle keratinization is removed, and pores are dredged; pathogenic bacterium infection is inhibited; acne injuries such as acne pits, acne marks, scars and pigmentation are repaired; the skin micro-ecology is balanced; the pores are shrunk. The composition is applied to skin beauty and skin medicine to effectively reduce the oil spot area, the oil intensity, the acne volume and the acne a value, and has the effects of resisting acnes and regulating the skin micro-ecology.
Owner:ZHUHAI GOLDEN PEPTIDE BIOTECHNOLOGY CO LTD +1

Metformin-loaded pegylated two-dimensional phosphorene nanosheet as well as preparation method and application thereof

The invention discloses a metformin-loaded pegylated two-dimensional phosphorene nanosheet as well as a preparation method and an application of the metformin-loaded pegylated two-dimensional phosphorene nanosheet. The preparation method comprises the following steps: preparing two-dimensional phosphorene nanosheets from black phosphorus crystals through a liquid phase stripping method; the preparation method comprises the following steps: mixing polyethylene glycol amino with a two-dimensional phosphorene nanosheet to prepare a pegylated two-dimensional phosphorene nanosheet; the preparation method comprises the following steps: mixing metformin with the pegylated two-dimensional phosphorene nanosheet, and removing free metformin, so as to obtain the metformin-loaded pegylated two-dimensional phosphorene nanosheet. The metformin-loaded pegylated phosphorene nanosheet disclosed by the invention has transdermal permeation and anti-oxidative stress capabilities, can deliver a drug into skin tissues, induces angiogenesis of hair follicles and promotes hair regeneration of an androgenetic alopecia animal model by removing excessive ROS (reactive oxygen species) in the surrounding environment of the hair follicles, and is degradable, so that the metformin-loaded pegylated phosphorene nanosheet disclosed by the invention has a good application prospect. The compound is safe and low in toxicity, and has good clinical application prospect and development value.
Owner:GUANGZHOU UNIVERSITY OF CHINESE MEDICINE

Abiraterone derivative as well as preparation method and application thereof

The invention provides an abiraterone derivative as well as a preparation method and application thereof. The abiraterone derivative has a chemical structural formula as shown in a formula (I). The abiraterone derivative disclosed by the invention can be converted into an active substance abiraterone in vivo, has the characteristics of good absorption, good plasma stability, ideal permeable membrane transport capability, good druggability and high safety, and can be used for treating diseases related to excessive androgen. # imgabs0 #
Owner:SHENZHEN NEPTUNUS PHARMA RES INST CO LTD

Methods and compositions for treating polycystic ovary syndrome

PCT designated stage expiredWO2025038392A1Organic active ingredientsPharmaceutical non-active ingredientsPhysiologyIncreased androgen level
Polycystic ovary syndrome (PCOS) is characterized by elevated levels of androgens, cysts in the ovaries, and irregular periods. Women with PCOS present with additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression and mood changes. The present disclosure provides new compounds, salts, compositions and uses thereof in the treatment of PCOS due to elevated adrenal androgens. Further, the present disclosure provides methods for treating PCOS due to elevated adrenal androgens.
Owner:SPRUCE BIOSCIENCES INC

Application of Schisandra chinensis extract in preparing preparations for treating hair loss or promoting hair regeneration

The present invention discloses the use of schisandra extract in a preparation for preventing and treating hair loss or promoting hair regeneration, belonging to the field of hair loss treatment. The schisandra of the present invention includes a combination of one or more of schisandra A and schisandra B. The present invention found that both schisandra A and schisandra B can significantly promote the proliferation of hair follicle cells; schisandra B can significantly promote hair regeneration after androgenic alopecia, and at the same time, the effect of promoting hair regeneration is related to the concentration of schisandra B. The present invention relates to a drug for treating hair loss, which includes schisandra A and schisandra B and a drug combination, as well as an optional pharmaceutically acceptable carrier. The drug can be prepared into different dosage forms such as external use solution, lotion, liniment, ointment, plaster, paste, patch, etc. for convenient use.
Owner:ZHEJIANG SCI-TECH UNIV